🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shenyang
Clinical trial register · China

Clinical Trials in Shenyang, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Shengjing Hospital46 General Hospital of Shenyang Military Region33 First Hospital of China Medical University21 China Medical University, China13 AstraZeneca12
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Shenyang

419 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Keverprazan vs Pantoprazole for the Treatment of ANVUGIB
NCT07776730Non-variceal Upper Gastrointestinal Bleeding
DrugPantoprazole
General Hospital of Shenyang Military Region
Not applicable
908
Shenyang
2026-10-01
Not yet open
Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes
NCT07557914HCC - Hepatocellular Carcinoma, Diabetes
DrugsEpalrestat·Donafenib·Tislelizumab
Haibo Shao
Phase 2
32
Shenyang
2026-10
Not yet open
Dyclonine vs. Tetracaine for Local Anesthesia in Unsedated Gastroscopy
NCT07691346Gastrointestinal Symptoms
General Hospital of Shenyang Military Region
Not applicable
208
Shenyang
2026-09-30
Not yet open
Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Variceal Bleeding and Renal Dysfunction
NCT07252401Liver Cirrhosis
DrugSomatostatin
General Hospital of Shenyang Military Region
Not applicable
64
Shenyang
2026-09-25
Not yet open
A Trial to Explore the Efficacy and Safety of O-triple as Initial Therapy in the Active Lupus Nephritis Patients (INITIAL Trial)
NCT07767188Lupus Nephritis
DrugObinutuzumab
Zhao Minghui
Phase 3
70
Fuzhou, Guangzhou, Harbin, Nanjing, Xuzhou, Nanchang, Shenyang, Yantai
2026-09-10
Not yet open
Sphere-9 PAF China Study
NCT07789925Paroxysmal Atrial Fibrillation (PAF)
Medtronic Cardiac Ablation Solutions
Not applicable
180
Beijing, Chengdu, Guangzhou, Hangzhou, Nanjing, Shanghai, Shenyang, Tianjin
2026-09-02
Not yet open
Culmerciclib Combined With Letrozole and Dual HER2 Blockade as Neoadjuvant Therapy for HR+/HER2+ Breast Cancer
NCT07795424Breast Cancer, HR Positive, HER2 Positive Breast Cancer
DrugsCulmerciclib·Pertuzumab·Letrozole·Trastuzumab
Shengjing Hospital
Phase 2
33
Shenyang
2026-09-01
Not yet open
Impact of Propranolol on the Prognosis of Patients With Decompensated Cirrhosis and MELD Score > 9
NCT07652203Cirrhosis
DrugPropranolol
General Hospital of Shenyang Military Region
Not applicable
466
Shenyang
2026-09
Not yet open
Auricular Acupressure for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy
NCT07760766Chemotherapy-induced Nausea and Vomiting
China Medical University, China
Not applicable
332
Shenyang
2026-09
Not yet open
A Clinical Study of SHR-4595 Injection in Patients With Advanced Solid Tumors to Evaluate Safety, Tolerability and Pharmacokinetics
NCT07830199Solid Tumor
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
208
Shenyang, Tianjin
2026-09
Not yet open
A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
NCT07678593Advanced Solid Tumors Cancer, Pancreatic Ductal Adenocarcinoma, RAS Mutation
DrugsGFH276·Leucovorin·Irinotecan·Nab-paclitaxel
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2
222
Beijing, Guangzhou, Harbin, Zhengzhou, Wuhan, Shenyang, Xi'an, Jinan
2026-09
Not yet open
A Phase 2 Study of ABSK043 Combined With Osimertinib
NCT07710612Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive
DrugsABSK043·Osimertinib
Abbisko Therapeutics Co, Ltd
Phase 2
72
Guangzhou, Harbin, Wuhan, Shenyang, Shanghai, Taiyuan, Hangzhou
2026-08-31
Recruiting
A Study of YL201 in Combination With Serplulimab in Participants With Treatment-naïve Extensive-stage Small Cell Lung Cancer
NCT07739758SCLC, Extensive Stage
DrugsTam-Peli·Serplulimab·Etoposide·Carboplatin
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 3
442
Guangzhou, Shenyang
2026-08-18
Not yet open
Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT
NCT07768085Hepatocellular Carcinoma (HCC), Intrahepatic Cholangiocarcinoma (Icc), Hepatic Metastasis, Hepatic Hemangioma
Shengjing Hospital
Not applicable
40,000
Shenyang
2026-08-17
Not yet open
Effects of Adaptive Difficulty Computerized Cognitive Training on Cognitive Function Improvement in Older Adults With Mild Cognitive Impairment
NCT07753382Cognitive Dysfunction, Cognitive Disorder, Cognitive Training
China Medical University, China
Not applicable
36
Shenyang
2026-08-10
Not yet open
A Study Comparing BL-M07D1 With Physician's Choice Therapy in Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Failed Prior Treatment With Oxaliplatin, Fluorouracil and Irinotecan
NCT07730489Colorectal Cancer
DrugsBL-M07D1·Regorafenib·Trifluridine/Tipiracil·Fruquintinib
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
130
Shenyang, Shanghai
2026-08
Recruiting
Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC
NCT07733830Esophageal Cancer
DrugsAdebrelimab·Nab-paclitaxel·Carboplatin
Tianjin Medical University Cancer Institute and Hospital
Phase 2
120
Beijing, Zhengzhou, Shenyang, Taiyuan, Chengdu, Tianjin
2026-07-31
Not yet open
A Phase I/II Study of FG-M108 Plus FG-B901 in Advanced CLDN18.2-Positive Solid Tumors
NCT07704866Claudin 18.2, Solid Tumor Malignancies
DrugsFG-B901·FG-M108
FutureGen Biopharmaceutical (Beijing) Co., Ltd
Phase 1/2
120
Ha’erbin, Shenyang
2026-07-30
Recruiting
Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents
NCT07693426Adolescence Obesity
DrugEfsubaglutide Alfa
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Phase 1
36
Beijing, Wuhan, Shenyang, Jinan
2026-07-16
Not yet open
Combined Magnetic Stimulation and Ultrasound for Detrusor Overactivity in SCI
NCT07704268Spinal Cord Injuries
Shengjing Hospital
Not applicable
44
Shenyang
2026-07-10
Recruiting
A Study of SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
NCT07660432Neoplasms, Malignant
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
472
Fuzhou, Zhengzhou, Changsha, Shenyang, Jinan, Hangzhou
2026-07-03
Not yet open
Effect of Cerebellar Fastigial Nucleus Stimulation Combined With Sling Exercise on Motor Function in Hemiplegic Stroke Patients
NCT07670936Stroke
Shengjing Hospital
Not applicable
54
Shenyang
2026-07-01
Not yet open
Effects of Exercise Sequence and Meal Sequence on Weight Management Among Children and Adolescents With Overweight or Obesity: The STEP Trial
NCT07712068Obesity & Overweight, Insulin Resistance, Inflamation
Peking University
Not applicable
480
Wuhu, Zhengzhou, Shenyang, Zibo, Shanghai, Hangzhou, Jinhua, Beijing
2026-07
Recruiting
A Study of IBI3031 in Participants With Thyroid Eye Disease
NCT07622368Thyroid Eye Disease
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
66
Shenyang
2026-06-30
Recruiting
Real-World Outcomes of Resected EGFR-Mutated NSCLC Patients Treated With Adjuvant EGFR-TKI in China
NCT07593248Lung Cancer
AstraZeneca
Observational
2,000
Beijing, Chengdu, Fuzhou, Guangzhou, Nanchang, Shanghai, Shenyang, Shijiazhuang
2026-06-22
Recruiting
Two-component Radiology-guided Autonomous Cascade Engine (TRACE)
NCT07651644Gastric Cancer (Diagnosis)
Liaoning Cancer Hospital & Institute
Not applicable
54
Shenyang
2026-06-18
Not yet open
A Clinical Study for the Safety and Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung Cancer
NCT07550842Small Cell Carcinoma of Lung
DrugsBL0020·Tislelizumab
Shanghai Best-Link Bioscience, LLC
Phase 1
33
Harbin, Zhengzhou, Wuhan, Changzhou, Shenyang, Taizhou, Shanghai
2026-06-16
Not yet open
Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial
NCT07699770Neuromyelitis Optica Spectrum Disorders (NMOSD), Neuropathic Pain
DrugCrisugabalin
Tang-Du Hospital
Phase 4
110
Beijing, Chongqing, Harbin, Hohhot, Changchun, Shenyang, Xi'an, Ürümqi
2026-06-15
Recruiting
Binaural Beats for Cognitive Function in Older Adults With Mild Cognitive Impairment in Nursing Homes
NCT07735910Mild Cognitive Impairment, Cognitive Function
China Medical University, China
Not applicable
60
Shenyang
2026-06-15
Active, closed
Induction Chemoimmunotherapy Followed by Deescalated Definitive Radiotherapy in Head and Neck Cancer
NCT07791602Head and Neck Squamous Cell Carcinoma, Locally Advanced Head and Neck Cancer, HNSCC
DrugTislelizumab
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
180
Beijing, Harbin, Shenyang, Taiyuan, Tianjin
2026-06-12
Recruiting
A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis
NCT07692165Ulcerative Colitis (UC)
Innatus Therapeutics (Shanghai) Co., Ltd.
Phase 1/2
24
Guangzhou, Shenyang, Beijing, Hangzhou, Shanghai, Taiyuan, Weifang, Wenzhou
2026-06-11
Recruiting
Precision Colchicine Intervention to Suppress Atherosclerosis in TET2 Clonal Hematopoiesis
NCT07362966Colchicine, Coronary Atherosclerosis Management, Clonal Hematopoiesis of Indeterminate Potential
Shenyang Northern Hospital
Phase 4
120
Shenyang
2026-06-08
Recruiting
Individualized Non-pharmacological Intervention for Bowel Preparation
NCT07684716Bowel Preparation for Colonoscopy
General Hospital of Shenyang Military Region
Not applicable
339
Shenyang
2026-06-08
Not yet open
A Multi-Center Randomized Controlled Trial on the Impact of Disease Subtype-Based Active Video Education on Bowel Preparation Quality in Patients With Inflammatory Bowel Disease
NCT07582731Inflammatory Bowel Diseases
Jie Liang
Not applicable
600
Beijing, Shenyang, Xining, Xi'an, Shanghai, Changzhi, Linfen, Yuncheng
2026-06-01
Recruiting
Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma: A Prospective Observational Study
NCT07652489Adenoid Cystic Carcinoma, Sinonasal Carcinoma
Eye & ENT Hospital of Fudan University
Observational
70
Harbin, Changsha, Shenyang, Shanghai, Xi’an, Wenzhou
2026-06-01
Not yet open
Treatment of Recurrent/Metastatic Head and Neck Cancer
NCT07601204Recurrent/Metastatic Head and Neck Cancer
DrugTQB2922
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 1/2
128
Beijing, Guangzhou, Nanning, Wuhan, Changsha, Shenyang, Taiyuan, Chengdu
2026-06
Recruiting
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
NCT07525206Colorectal Cancer
DrugsTelisotuzumab Adizutecan·Trifluridine/Tipiracil·Bevacizumab
AbbVie
Phase 3
990
Beijing, Guangzhou, Nanning, Wuhan, Changchun, Shenyang, Yinchuan, Jinan
2026-05-22
Recruiting
Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus
NCT07483359Hepatocellular Carcinoma (HCC), Portal Vein Tumor Thrombus
First Hospital of China Medical University
Phase 2
38
Shenyang
2026-05-20
Active, closed
LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia
NCT07350486Hypertension, Diabetes, Dyslipidemia
First Hospital of China Medical University
Not applicable
6,800
Cangzhou, Suzhou, Panjin, Shenyang, Jinzhou, Tianjin
2026-05-14
Recruiting
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
NCT07415031Solid Tumors
DrugsAdagrasib·Leucovorin·Irinotecan·Oxaliplatin
Mirati Therapeutics Inc.
Phase 2
170
Beijing, Xiamen, Zhengzhou, Changsha, Nanjing, Nanchang, Shenyang, Jinan
2026-05-06
Recruiting
Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Prourokinase
NCT07550296Acute Ischemic Stroke
General Hospital of Shenyang Military Region
Phase 2
122
Shenyang
2026-05-06
Recruiting
First-in-Human Study of the Radioligand 68Ga- DOTA-EphA2
NCT07593209Malignant Tumor
First Hospital of China Medical University
Observational
30
Shenyang
2026-05-01
Recruiting
Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts
NCT07534865Warts
DrugHydrogen Peroxide
First Hospital of China Medical University
Not applicable
210
Shenyang
2026-05-01
Not yet open
A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus Erythematosus
NCT07557927Discoid Lupus Erythematosus
DrugsDihydroartemisinin·Hydroxychloroquine
Kunming Pharmaceuticals, Inc.
Phase 2
100
Hefei, Beijing, Chongqing, Guangzhou, Changsha, Shenyang, Kunming, Hangzhou
2026-04-30
Not yet open
Effects of High-frequency Left Dorsolateral Prefrontal rTMS on Heart-brain Coupling in Women With Recurrent Pregnancy Loss and Elevated BMI
NCT07561931Recurrent Pregnancy Loss, Overweight , Obesity, Heart-Brain Coupling
Shenyang Medical College
Not applicable
60
Shenyang
2026-04-28
Not yet open
Right Dorsolateral Prefrontal Cortex Closed-loop Neurofeedback for Anxiety in High-ischaemic-risk Chronic Coronary Syndrome
NCT07543185Chronic Coronary Syndrome, Anxiety Disorder, High Ischemic Risk
Shenyang Medical College
Not applicable
214
Shenyang
2026-04-19
Not yet open
A Phase III Study of MG-K10 in Adolescents With Moderate-to-Severe Atopic Dermatitis
NCT07540442Dermatitis, Atopic
DrugMG-K10
Shanghai Mabgeek Biotech.Co.Ltd
Phase 3
180
Shenyang
2026-04-17
Active, closed
A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors
NCT07749703Histologically or Cytologically Confirmed Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
346
Hefei, Shenyang, Jinan, Shanghai, Hangzhou
2026-03-31
By invitation
Pantoprazole After Prophylactic Endoscopic Variceal Treatment
NCT07248722Esophageal and Gastric Varices, Liver Cirrhosis
DrugPantoprazole
General Hospital of Shenyang Military Region
Not applicable
208
Shenyang
2026-03-27
Recruiting
Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK)
NCT07375953Ischemic Stroke
DrugTenecteplase
General Hospital of Shenyang Military Region
Phase 2
120
Shenyang
2026-03-25
Recruiting
Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)
NCT07375966Ischemic Stroke
DrugTenecteplase
General Hospital of Shenyang Military Region
Phase 2
198
Shenyang
2026-03-25
Recruiting
Transcranial Doppler for Internal Carotid Artery Stenting (TCD-ICAS)
NCT07462546Artery Stenosis
General Hospital of Shenyang Military Region
Not applicable
232
Shenyang
2026-03-24
Recruiting
A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis
NCT07309055Adolescents With Moderate-to-severe Atopic Dermatitis
DrugSHR-1819
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 3
201
Shenyang, Shanghai
2026-03-21
Recruiting
Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder
NCT07480525Depression - Major Depressive Disorder
DrugEscitalopram
Peking University
Not applicable
200
Beijing, Baoding, Shijiazhuang, Shenyang, Jinan
2026-03-20
Not yet open
Lithotripsy Versus Balloon Angioplasty for Optimal Treatment of CAlcified Lesions With and Without Optical Coherence Tomography evaluatION
NCT07388030Coronary Artery Disease, Severe Coronary Artery Disease, Coronary Artery Calcification
Shanghai Bluesail Boyuan Medical Technology Co., Ltd.
Not applicable
3,060
Shenyang
2026-03-20
Recruiting
Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's Disease
NCT07294885Alzheimer Disease
General Hospital of Shenyang Military Region
Not applicable
50
Shenyang
2026-03-20
Not yet open
Efficacy and Safety of Sanyong Jiedu Granules in Treating Lumps-Type Non-Lactational Mastiti
NCT07512648Plasmacytic Mastitis, Granulomatous Lobular Mastitis
Caigang Liu
Not applicable
210
Shenyang
2026-03-20
Recruiting
A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects
NCT07446153Solid Tumor
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
282
Guangzhou, Shenyang
2026-03-19
Recruiting
A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases
NCT07412691Skin Diseases
BeOne Medicines
Phase 1
98
Beijing, Chongqing, Fuzhou, Shijiazhuang, Changsha, Suzhou, Shenyang, Shanghai
2026-03-19
Recruiting
Study on the Pathogenesis and Reversal Strategies of Cancer Cachexia Based on Multi-Omics
NCT07519837Cachexia; Cancer; Sarcopenia
China Medical University, China
Not applicable
1,000
Shenyang
2026-03-18
Active, closed
An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps
NCT07424144Chronic Rhinosinusitis With Nasal Polyps
DrugItepekimab
Sanofi
Phase 3
59
Baotou, Beijing, Chengdu, Jingzhou, Shenyang, Taiyuan
2026-03-12
Recruiting
ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)
NCT06951646Non Small Cell Lung Cancer, Immune Checkpoint Inhibitors (ICIs)
DrugsBevacizumab·Paclitaxel
Second Xiangya Hospital of Central South University
Phase 2
70
Changsha, Chongqing, Guiyang, Hong Kong, Macao, Nanchang, Nanning, Shenyang
2026-03-10
Recruiting
Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis
NCT07412249Carotid Stenosis
General Hospital of Shenyang Military Region
Not applicable
300
Shenyang
2026-03-04
Recruiting
Edaravone and Dexborneol Sublingual Tablet for Treating Chemotherapy- Induced Cognitive Impairment Study
NCT07454473Chemo Brain
DrugEdaravone Dexborneol
Chuansheng Zhao
Phase 4
80
Shenyang
2026-03-02
Not yet open
Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy
NCT07471282Stroke
DrugTenecteplase
Chuansheng Zhao
Phase 3
344
Shenyang
2026-03-01
Not yet open
Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk
NCT07374718Acute Coronary Syndrome (ACS), High Bleeding Risk(HBR), Coronary Artery Disease (CAD)
Shenyang Northern Hospital
Not applicable
468
Shenyang
2026-03-01
Recruiting
Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis
NCT07503652Palmoplantar Pustulosis (PPP)
DrugXeligekimab
First Hospital of China Medical University
Phase 4
10
Shenyang
2026-03
Not yet open
CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes in Non-diabetic ACS Patients Without HF
NCT07351643ACS (Acute Coronary Syndrome), SGLT2 Inhibitors
DrugDapagliflozin
Shenyang Northern Hospital
Phase 4
110
Shenyang
2026-02-25
By invitation
Interventional AI-Human Collaboration for Steatotic Liver Disease Screening
NCT07613827Steatotic Liver Disease, Liver Fibrosis Progression in Chronic Liver Disease, Liver Steatosis, Liver Fibrosis
Shengjing Hospital
Not applicable
7,969
Shenyang
2026-02-24
Not yet open
A Multi-modal Integrating Imaging and Cell-free DNA Methylation in Lung Cancer Early Detection (CMe-Lung): a Multi-center, Observational Study
NCT07375979Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Observational
14,300
Shijiazhuang, Zhengzhou, Changchun, Shenyang, Shanghai, Kunming
2026-02-05
Recruiting
Efficacy of Montelukast on STEMl Patients
NCT07320625Myocardial Infarction (MI)
DrugMontelukast
Shanghai Zhongshan Hospital
Phase 3
512
Dalian, Shanghai, Fuzhou, Guangdong, Ha’erbin, Hefei, Hunan, Shenyang
2026-02-01
Active, closed
Human Umbilical Cord-mesenchymal Stem Cells Via Different Transplantation Routes in ESLD
NCT06984497End-Stage Liver Diseases
General Hospital of Shenyang Military Region
Not applicable
32
Shenyang
2026-02-01
Not yet open
A Phase III Study of GS101 Injection to Dupixent®
NCT07386743Atopic Dermatitis (AD)
DrugDupilumab
Jiangsu Genscend Biopharmaceutical Co., Ltd
Phase 3
572
Shenyang
2026-02
Recruiting
A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
NCT07281976Triple Negative Breast Cancer
DrugsLBL-024·Albumin-Bound Paclitaxel·Tislelizumab
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2
220
Guangzhou, Harbin, Zhengzhou, Nanjing, Changchun, Shenyang
2026-01-27
Recruiting
Tenecteplase Plus Urinary Kallidinogenase for Acute Ischemic Stroke (TUKIS)
NCT07283159Ischemic Stroke
DrugHuman Urinary Kallidinogenase
General Hospital of Shenyang Military Region
Phase 2
200
Shenyang
2026-01-20
Recruiting
First in Human Study of SIM0610 in Solid Tumors
NCT07348211Advanced Solid Tumours, Non-Small Cell Lung Cancer, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
260
Chongqing, Harbin, Shenyang, Jinan, Shanghai
2026-01-19
Recruiting
A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.
NCT07520565AIS
Biocells (Beijing) Biotech Co.,Ltd
Phase 3
1,112
Hengshui, Daqing, Nanyang, Meihekou, Shenyang, Xianyang, Linyi, Linfen
2026-01-19
Recruiting
Effects of Short-term Intensive Statin Therapy on Lipid Levels
NCT07344610Ischemic Stroke
General Hospital of Shenyang Military Region
Observational
800
Shenyang
2026-01-08
Recruiting
The Optimal Measurement Time for the New Gallbladder Function Assessment Method
NCT07321431Gallbladder; Functional Disturbance
Hepatopancreatobiliary Surgery Institute of Gansu Province
Not applicable
120
Lanzhou, Qinhuangdao, Shenyang, Yinchuan, Xi’an
2026-01-07
Recruiting
Adding Evolocumab to Conventional Lipid-lowering Therapy for Hypertriglyceridemia Induced Acute Pancreatitis
NCT07388420Hypertriglyceridemia Induced Acute Pancreatitis
DrugEvolocumab
General Hospital of Shenyang Military Region
Not applicable
40
Shenyang
2026-01-02
Recruiting
SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure
NCT07311408Gastric Cancer (GC), Gastroesophageal Junction Adenocarcinoma
DrugsRivoceranib·SHR-1701
Jingdong Zhang
Phase 2
40
Shenyang
2026-01-01
Not yet open
Multicenter RCT: LED Red Light Dose-Response in Myopia Progression Control
NCT07330180Myopia, Myopia, Progressive
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
364
Chongqing, Foshan, Zhengzhou, Wuhan, Shenyang, Guilin, Xi’an
2026-01-01
Recruiting
A Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast Ducts
NCT07339306Mammary Tumor, Nipple Discharge, Breast Ductal Carcinoma In Situ
The Fourth Affiliated Hospital of China Medical University
Not applicable
300
Shenyang
2026-01-01
Not yet open
Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy
NCT07354828Acute Coronary Syndrome (ACS), High Bleeding Risk (HBR), Coronary Artery Disease (CAD)
Shenyang Northern Hospital
Observational
3,500
Shenyang
2025-12-30
Recruiting
Cardiac Autonomic and Anxiety Regulation Via Closed-loop nEurofeedback in Recurrent Pregnancy Loss
NCT07325370Recurrent Pregnancy Loss, Anxiety
Shenyang Medical College
Not applicable
62
Shenyang
2025-12-29
Not yet open
Digital Technology Combined With Blood Marker Screening and Diagnosis for Community Populations Based on Classification Theory: an Integrated Study
NCT07286812Alzheimer Disease
First Hospital of China Medical University
Observational
1,000
Shenyang
2025-12-25
Recruiting
A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors
NCT07228247Solid Tumors, Adult
Hutchmed
Phase 1/2
147
Beijing, Changsha, Guangzhou, Hefei, Shanghai, Shenyang, Zhengzhou
2025-12-16
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of GenSci140 in Participants With Advanced Solid Tumors
NCT07251166Advanced Solid Tumors
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
170
Shenyang
2025-12-10
Not yet open
Orlistat and Weight Management for Uric Acid Control in Obese Gout: A RCT
NCT07326839Gout, Obesity
DrugOrlistat
XueMei Guo
Not applicable
120
Shenyang
2025-12-10
Recruiting
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
NCT07283835Non Muscle Invasive Bladder Cancer, High-grade Ta/ T1 Papillary Disease Bladder Cancer
DrugCretostimogene Grenadenorepvec
Lepu Biopharma Co., Ltd.
Phase 2
16
Beijing, Chongqing, Fuzhou, Wuhan, Changsha, Nanjing, Shenyang, Jinan
2025-12-04
Active, closed
A Study of DII235 in Adults With Elevated Lipoprotein(a)
NCT07235046Lipoprotein Disorder
Novartis Pharmaceuticals
Phase 2
234
Luoyang, Shenyang, Wenzhou, Beijing
2025-12-02
Recruiting
A Study of LBL-024 in Combination With Paclitaxel ± Bevacizumab for the Treatment of Platinum-resistant Ovarian Cancer
NCT07042802Ovarian Cancer
DrugsLBL-024·Bevacizumab·Paclitaxel
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2
180
Beijing, Fuzhou, Guangzhou, Harbin, Anyang, Zhengzhou, Xuzhou, Shenyang
2025-12-02
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Nab-paclitaxel·Pemetrexed
AstraZeneca
Phase 1/2
152
Chengdu, Chongqing, Deyang, Fuzhou, Guangzhou, Jinan, Shanghai, Shenyang
2025-11-24
Recruiting
Closed-Loop Neurofeedback Targeting the Left Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety
NCT07244484Coronary Heart Disease (CHD), Anxiety Disorders
Shenyang Medical College
Not applicable
56
Shenyang
2025-11-23
Recruiting
A Study of GensSci098 in Subjects With Graves' Disease
NCT07286656Safety, Tolerability, GenSci098, Graves Disease
DrugGenSci098
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
24
Shenyang
2025-11-21
Recruiting
A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])
NCT07208058Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis
DrugPlonmarlimab
TJ Biopharma Co., Ltd.
Phase 3
30
Beijing, Guangzhou, Nanning, Shijiazhuang, Zhengzhou, Wuhan, Nanchang, Shenyang
2025-11-21
Recruiting
The Long-term Effect of Remote Ischemic Conditioning on Main Organs in ASVCD Patients With Very High Risks
NCT07270887ASCVD
General Hospital of Shenyang Military Region
Observational
2,800
Shenyang
2025-11-19
Recruiting
High-Intensity, Low-Frequency Periodic rTMS Over the Right Dorsolateral Prefrontal Cortex on Cardiac Autonomic Regulation in Women With Recurrent Pregnancy Loss and Anxiety
NCT07233278Recurrent Pregnancy Loss(RPL), Anxiety
Shenyang Medical College
Not applicable
48
Shenyang
2025-11-19
Recruiting
Closed-Loop Neurofeedback Targeting the Right Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety
NCT07238920Coronary Heart Disease (CHD), Anxiety Disorders
Shenyang Medical College
Not applicable
56
Shenyang
2025-11-19
Recruiting
Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban
NCT07135089Stroke, Ischemic
General Hospital of Shenyang Military Region
Phase 3
870
Shenyang
2025-11-13
Rows per page Showing 1–100 of 419
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/shenyang

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 419 of those studies with a site in Shenyang.

How many clinical trials are recruiting in Shenyang?

253 of the 419 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 55 have not yet opened recruitment, 101 are active but closed to new participants, and 10 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Shenyang), 419 studies
PhaseStudiesRecruitingShare
Not applicable1046224.8%
Phase 3783118.6%
Observational746017.7%
Phase 2693916.5%
Phase 137268.8%
Phase 1/232227.6%
Phase 41683.8%
Phase 2/3851.9%
Phase EARLY_PHASE1100.2%

Most active sponsors

Lead sponsors with the most studies (Shenyang)
Lead sponsorStudiesRecruiting
Shengjing Hospital4634
General Hospital of Shenyang Military Region3326
First Hospital of China Medical University2115
China Medical University, China139
AstraZeneca125
AbbVie103
Novartis Pharmaceuticals95
Shenyang Northern Hospital94
Sanofi81
BeOne Medicines65
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.